No registrations found.
ID
Source
Brief title
Health condition
22q11 CNV
cognitie schizofrenie psychopathologie.
22q11 CNV cognition schizophrenia psychopathology
Sponsors and support
Intervention
Outcome measures
Primary outcome
Neuropsychological outcome measures (working memory, attention, social cognition,verbal memory, processing speed, visual memory, planning), a cognitive composite score bases on the total score of the CANTAB subtests (representing cognitive function), IQ, psychiatric diagnosis
Secondary outcome
n/a
Background summary
The 22q11.2 chromosomal region is one of the regions that has received interest from psychiatric geneticists for over 20 years. A deletion at 22q11.2 is the first and only copy number variant (CNV) unequivocally implicated in schizophrenia, and this was known long before genome-wide analysis of CNVs for schizophrenia were published. In up to 30% of people carrying the deletion at 22q11.2, a psychotic picture fulfilling the DSM criteria for schizophrenia emerges during adolescence or adulthood. More recently, duplication of the same chromosomal region has been associated with a distinct syndrome, but with several features overlapping with 22q11.2 deletion syndrome including velopharyngeal insufficiency, congenital cardiac anomalies, cognitive deficits, behavioural problems, and psychiatric disorders like autism and attention-deficit hyperactivity disorder. Interestingly, psychotic disorders associated with 22q11.2 duplication have not yet been reported in the literature, which is possible due to the fact that most cases described to date involved children. Moreover, results from a recent hallmark study suggest that duplications at 22q11.2 might protect against schizophrenia.
Study objective
Psychopathology and Cognition in 22q11 CNV disorders
Study design
one
Intervention
The study design concerns an observational cross-sectional study investigating cognitive and psychopathological profiles in 22q11CNV disorders
Claudia Vingerhoets
Vijverdalseweg 1
Maastricht 6226 NB
The Netherlands
+3143 388 4158
claudia.vingerhoets@maastrichtuniversity.nl
Claudia Vingerhoets
Vijverdalseweg 1
Maastricht 6226 NB
The Netherlands
+3143 388 4158
claudia.vingerhoets@maastrichtuniversity.nl
Inclusion criteria
-A deletion or duplication at chromosome 22q11.2 confirmed by FISH, micro-array or MLPA analysis.
-Ability to give informed consent
-Written informed consent by participant.
-Age 18-65 years
Exclusion criteria
-Other chromosomal abnormalities
Design
Recruitment
IPD sharing statement
Followed up by the following (possibly more current) registration
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL5118 |
NTR-old | NTR5250 |
CCMO | NL50158.068.14 |
OMON | NL-OMON47626 |